Cellectar Biosciences (NV40) Cash flow

1 Followers

Cellectar Biosciences Cash Flow

DE:NV40's free cash flow for Q2 2026 was $-6.01M. For the 2026 fiscal year, DE:NV40's free cash flow was decreased by $24.56M and operating cash flow was $-6.01M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -23.12M	$ -47.58M	$ -32.38M	$ -25.22M	$ -22.57M
Investing Cash Flow	$ -5.88K	$ -104.19K	$ -864.04K	$ -225.97K	$ -141.36K
Financing Cash Flow	$ 13.03M	$ 61.41M	$ 22.94M	$ 9.61M	$ 1.25M
End Cash Position	$ 13.20M	$ 23.29M	$ 9.56M	$ 19.87M	$ 35.70M
Free Cash Flow	$ -23.12M	$ -47.69M	$ -33.24M	$ -25.45M	$ -22.71M

Currency in USD